Bain Capital and Botanic Properties have broken ground on a unique biomanufacturing facility in Bedford, Mass., which is designed to house multiple companies operating separately in highly ...

The company will begin with five potential treatments for autoimmune diseases in-licensed from Bristol Myers Squibb, which will retain 20% equity in the new company.

The latest international Bain Capital Partners XII, LLC news and views from Reuters - one of the world's largest news agencies ...

Conference ID: BAIN All participants will need to reference “Bain Capital Specialty Finance - Second Quarter Ended June 30, 2025 Earnings Conference Call” once connected with the operator.

Bain Capital and Bristol Myers Squibb form new biopharma company The newly formed company launches with a $300 million financing commitment led by Bain Capital.

Drugmaker Bristol Myers Squibb and private equity firm Bain Capital will launch an independent company focused on developing immunology drugs, backed by Bain's $300 million financing round, the ...

PRINCETON, N.J. & BOSTON-- (BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY, “BMS”) and Bain Capital today announced the creation of a new independent biopharmaceutical company (“NewCo ...

Bain Capital and Bristol Myers Squibb are providing financial and scientific support to a new startup working on autoimmune drugs.

American private investment firm Bain Capital is on the verge of acquiring a significant stake in Manappuram Finance, one of Kerala’s leading gold loan providers, in a deal valued at ...

Bain Capital pumps capital into Germany’s Sdui Group Sdui is a European provider of cloud-based administrative software for K-12 schools.

Lincoln National Corporation (NYSE:LNC), a leading U.S. provider of insurance and retirement solutions, is advancing its strategy in 2025 through a major partnership with Bain Capital.